Rulemaking improvement project

Ended Awarded Last action

Contract number
HHSF22312012
Awardee
Awarding agency
Obligated
$970,642

Award facts

Contract value 100% obligated
$970,642.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20036, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Deobligate $33,972.48 and close. -$33,972
Original award $1,004,615

About this award

The Food and Drug Administration issued a BPA call to McKinsey & Company, Inc. under the Professional Services Schedule with a ceiling value of $970,642.32, awarded on September 10, 2012. The call, titled Rulemaking Improvement Project, is a firm fixed-price engagement with place of performance in Washington, DC 20036. The ultimate completion date is April 14, 2015. The source indicates a deobligation of $33,972.48 and call closure. No set-aside was applied.

Quick answers

Who was awarded contract HHSF22312012?

HHSF22312012 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2012.

How much is contract HHSF22312012 worth?

The government has obligated $970,642 on HHSF22312012.

Is contract HHSF22312012 an order under another contract?

Yes. HHSF22312012 is a BPA call under GS10F0118S-HHSF223201010014B, a blanket purchase agreement, on The Professional Services Schedule (PSS).

Was contract HHSF22312012 competed?

The extent of competition for HHSF22312012 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award